Lingnan Li

Lingnan Li has extensive work experience in the biostatistics field. They started their career as a Statistics Co-op at GlaxoSmithKline in 2015. From 2016 to 2021, they worked at Eli Lilly and Company, initially as a Research Scientist and later as a Senior Research Scientist. In 2021, they joined Gemini Therapeutics as an Associate Director of Biostatistics, and in 2022, they moved to Prothena Corporation plc, where they currently hold the position of Associate Director of Biostatistics.

Lingnan Li completed their Bachelor of Science (B.S.) degree in Mathematics and Applied Mathematics at the University of Science and Technology of China from 2005 to 2009. Lingnan pursued further education at Indiana University–Purdue University Indianapolis from 2009 to 2012, earning their Master of Science (M.S.) degree in Mathematics with a specialization in Applied Statistics. Lingnan then attended Purdue University from 2009 to 2016, where they obtained their Doctor of Philosophy (Ph.D.) degree in Statistics.